semaglutide cardiac protection cardiovascular outcomes align more closely with attained dose than achieved weight loss Ozempic and Mounjaro: Saving Your

The peptide activates endothelial nitric oxide synthase (eNOS) through both VEGFR2-dependent and VEGFR2-independent pathways

10.1016/j.cell.2017.09.021 Cell 150 SunX.OuZ.XieM.KangR.FanY.NiuX.et al (2015)

While semaglutide is not approved to treat alcohol use disorder, growing anecdotal evidence and mechanistic studies suggest a potential link between GLP-1 activation and reduced drinking behavior

This delay can change how quickly topiramate reaches its peak levels in your blood

Take a GLP-1specific history The consultation should document the agent, indication, starting date, dose-escalation schedule and any treatment interruptions